Emily Sammons Selected Research

Aspirin (Acetylsalicylic Acid)

10/2023	ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration.
10/2018	Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emily Sammons Research Topics

Disease

3	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 10/2018
2	Diabetes Mellitus 10/2018 - 10/2018
1	Kidney Diseases (Kidney Disease) 12/2023
1	Heart Failure 12/2023
1	Chronic Renal Insufficiency 12/2023
1	Disease Progression 12/2023
1	Macular Degeneration (Age-Related Maculopathy) 10/2023
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2023
1	Hemorrhage 10/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2018
1	Neoplasms (Cancer) 10/2018
1	Vascular Diseases (Vascular Disease) 01/2017

Drug/Important Bio-Agent (IBA)

2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 10/2018
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2023 - 10/2018
1	AlbuminsIBA 12/2023
1	CreatinineIBA 12/2023
1	empagliflozinIBA 12/2023
1	Olive OilIBA 10/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2018
1	LDL CholesterolIBA 01/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017
1	HDL CholesterolIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	anacetrapibIBA 01/2017
1	Atorvastatin (Lipitor)FDA Link 01/2017

Therapy/Procedure

2	Therapeutics 12/2023 - 01/2017
1	Secondary Prevention 10/2023